» Articles » PMID: 28539360

A Dock and Coalesce Mechanism Driven by Hydrophobic Interactions Governs Cdc42 Binding with Its Effector Protein ACK

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2017 May 26
PMID 28539360
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Cdc42 is a Rho-family small G protein that has been widely studied for its role in controlling the actin cytoskeleton and plays a part in several potentially oncogenic signaling networks. Similar to most other small G proteins, Cdc42 binds to many downstream effector proteins to elicit its cellular effects. These effector proteins all engage the same face of Cdc42, the conformation of which is governed by the activation state of the G protein. Previously, the importance of individual residues in conferring binding affinity has been explored for residues within Cdc42 for three of its Cdc42/Rac interactive binding (CRIB) effectors, activated Cdc42 kinase (ACK), p21-activated kinase (PAK), and Wiskott-Aldrich syndrome protein (WASP). Here, in a complementary study, we have used our structure of Cdc42 bound to ACK via an intrinsically disordered ACK region to guide an analysis of the Cdc42 interface on ACK, creating a panel of mutant proteins with which we can now describe the complete energetic landscape of the Cdc42-binding site on ACK. Our data suggest that the binding affinity of ACK relies on several conserved residues that are critical for stabilizing the quaternary structure. These residues are centered on the CRIB region, with the complete binding region anchored at each end by hydrophobic interactions. These findings suggest that ACK adopts a dock and coalesce binding mechanism with Cdc42. In contrast to other CRIB-family effectors and indeed other intrinsically disordered proteins, hydrophobic residues likely drive Cdc42-ACK binding.

Citing Articles

The transition state for coupled folding and binding of a disordered DNA binding domain resembles the unbound state.

Kuravsky M, Kelly C, Redfield C, Shammas S Nucleic Acids Res. 2024; 52(19):11822-11837.

PMID: 39315703 PMC: 11514473. DOI: 10.1093/nar/gkae794.


Domain Architecture of the Nonreceptor Tyrosine Kinase Ack1.

Kan Y, Paung Y, Seeliger M, Miller W Cells. 2023; 12(6).

PMID: 36980241 PMC: 10047419. DOI: 10.3390/cells12060900.


Regulation of Cdc42 protein turnover modulates the filamentous growth MAPK pathway.

Gonzalez B, Cullen P J Cell Biol. 2022; 221(12).

PMID: 36350310 PMC: 9811999. DOI: 10.1083/jcb.202112100.


The role of cell division control protein 42 in tumor and non-tumor diseases: A systematic review.

Fu J, Liu B, Zhang H, Fu F, Yang X, Fan L J Cancer. 2022; 13(3):800-814.

PMID: 35154449 PMC: 8824883. DOI: 10.7150/jca.65415.


Classification of protein-protein association rates based on biophysical informatics.

Dhusia K, Wu Y BMC Bioinformatics. 2021; 22(1):408.

PMID: 34404340 PMC: 8371850. DOI: 10.1186/s12859-021-04323-0.


References
1.
Hemsath L, Dvorsky R, Fiegen D, Carlier M, Ahmadian M . An electrostatic steering mechanism of Cdc42 recognition by Wiskott-Aldrich syndrome proteins. Mol Cell. 2005; 20(2):313-24. DOI: 10.1016/j.molcel.2005.08.036. View

2.
Thompson G, Owen D, Chalk P, Lowe P . Delineation of the Cdc42/Rac-binding domain of p21-activated kinase. Biochemistry. 1998; 37(21):7885-91. DOI: 10.1021/bi980140+. View

3.
Lei M, Lu W, Meng W, Parrini M, Eck M, Mayer B . Structure of PAK1 in an autoinhibited conformation reveals a multistage activation switch. Cell. 2000; 102(3):387-97. DOI: 10.1016/s0092-8674(00)00043-x. View

4.
Morreale A, Venkatesan M, Mott H, Owen D, Nietlispach D, Lowe P . Structure of Cdc42 bound to the GTPase binding domain of PAK. Nat Struct Biol. 2000; 7(5):384-8. DOI: 10.1038/75158. View

5.
Dogan J, Gianni S, Jemth P . The binding mechanisms of intrinsically disordered proteins. Phys Chem Chem Phys. 2013; 16(14):6323-31. DOI: 10.1039/c3cp54226b. View